Shock therapy for dementia agitation? new trial tests ECT

NCT ID NCT03926520

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This study tests whether adding electroconvulsive therapy (ECT) to usual care can safely reduce severe agitation in people with moderate to severe dementia, including Alzheimer's and other types. Fifty participants will receive ECT sessions with anesthesia, and researchers will measure changes in agitation using a standard scale. The goal is to see if ECT can provide quick relief when other treatments have failed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Electroconvulsive therapy (ECT) using right unilateral electrode placement and ultra-brief pulse width
What this could lead to
If it works, this could offer a new option to quickly calm severe agitation in dementia patients who haven't responded to other treatments.
What could go wrong
This is a small early study with only 50 participants, so results may not apply to everyone. ECT carries risks from anesthesia and possible memory side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGITATION,PSYCHOMOTOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Emory Healthcare

    Atlanta, Georgia, 30308, United States

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • McLean Hospital

    Belmont, Massachusetts, 02478, United States

  • Northwell Health

    Glen Oaks, New York, 11004, United States

  • Pine Rest Christian Mental Health Services

    Grand Rapids, Michigan, 49548, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.